BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

OBJECTIVE: Animal models suggest that BRCA1/2 mutations increase doxorubicin-induced cardiotoxicity risk but data in humans are limited. We aimed to determine whether germline BRCA1/2 mutations are associated with cardiac dysfunction in breast cancer survivors. METHODS: In a single-center cross-sect...

Descripción completa

Detalles Bibliográficos
Autores principales: Demissei, Biniyam G., Lv, WenJian, Wilcox, Nicholas S., Sheline, Karyn, Smith, Amanda M., Sturgeon, Kathleen M., McDermott-Roe, Chris, Musunuru, Kiran, Lefebvre, Bénédicte, Domchek, Susan M., Shah, Payal, Ky, Bonnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885808/
https://www.ncbi.nlm.nih.gov/pubmed/35242827
http://dx.doi.org/10.3389/fcvm.2022.833171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885808/
https://www.ncbi.nlm.nih.gov/pubmed/35242827
http://dx.doi.org/10.3389/fcvm.2022.833171

Ejemplares similares